Biotechnology company I-Tech reported a decline in revenue for the fourth quarter compared to the same period last year. Operating profit also decreased. The board is proposing an increase in the regular dividend.

Revenue fell by 33.0 percent to 38.7 million kronor (57.8). The period continues to be marked by the underperformance of the company's second-largest customer, both compared to expectations and the previous year.

Operating profit amounted to 7.6 million kronor (16.8), with an operating margin of 19.6 percent (29.1).

Profit after tax was 6.4 million kronor (14.3), a decrease of 55.2 percent compared to the previous year.

The proposed regular dividend is 1.25 kronor per share (1.00).

Cash and cash equivalents totaled 148.2 million kronor (100.2).

Operating cash flow was 12.6 million kronor (6.2).

"To manage the workload associated with building a more diversified I-Tech, investments are therefore being made in organization and capabilities. The team is preparing to welcome several new permanent employees during the first half of 2026 and looks forward to another exciting year," says CEO Markus Jönsson.

I-Tech, MkrQ4-2025Q4-2024Change
Net revenue38.757.8-33.0%
Operating profit7.616.8-54.8%
Operating margin19.6%29.1%
Net profit6.414.3-55.2%
Cash and cash equivalents148.2100.247.9%
Regular annual dividend per share, kronor1.251.0025.0%